Eli Lilly & Co. (LLY)
1157.93
-16.68
(-1.42%)
USD |
NYSE |
Aug 31, 16:00
1161.07
+3.14
(+0.27%)
After-Hours: 20:00
Eli Lilly Cash from Operations (Annual) : 16.81B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 16.81B |
| December 31, 2024 | 8.818B |
| December 31, 2023 | 4.240B |
| December 31, 2022 | 7.084B |
| December 31, 2021 | 7.261B |
| December 31, 2020 | 6.500B |
| December 31, 2019 | 4.837B |
| December 31, 2018 | 5.524B |
| December 31, 2017 | 5.616B |
| December 31, 2016 | 4.851B |
| December 31, 2015 | 2.773B |
| December 31, 2014 | 4.367B |
| December 31, 2013 | 5.735B |
| December 31, 2012 | 5.305B |
| December 31, 2011 | 7.234B |
| December 31, 2010 | 6.857B |
| December 31, 2009 | 4.336B |
| December 31, 2008 | 7.296B |
| December 31, 2007 | 5.154B |
| December 31, 2006 | 3.976B |
| December 31, 2005 | 1.914B |
| December 31, 2004 | 2.870B |
| Date | Value |
|---|---|
| December 31, 2003 | 3.647B |
| December 31, 2002 | 2.071B |
| December 31, 2001 | 3.662B |
| December 31, 2000 | 3.732B |
| December 31, 1999 | 2.620B |
| December 31, 1998 | 2.630B |
| December 31, 1997 | 2.400B |
| December 31, 1996 | 1.991B |
| December 31, 1995 | 1.825B |
| December 31, 1994 | 1.532B |
| December 31, 1993 | 1.517B |
| December 31, 1992 | 1.484B |
| December 31, 1991 | 1.255B |
| December 31, 1990 | 1.474B |
| December 31, 1989 | 1.033B |
| December 31, 1988 | 689.60M |
| December 31, 1987 | 795.40M |
| December 31, 1986 | 888.90M |
| December 31, 1985 | 560.20M |
| December 31, 1984 | 633.50M |
| December 31, 1983 | 684.30M |
| December 31, 1982 | 574.29M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Johnson & Johnson | 24.53B |
| Merck & Co., Inc. | 16.47B |
| Pfizer Inc. | 11.70B |
| Bristol Myers Squibb Co. | 14.16B |
| Atai Beckley, Inc. | -102.68M |